Line eliminating method immunochromatography test paper and application thereof in CRISPR nucleic acid test

An immunochromatographic test paper and nucleic acid technology, which can be used in biochemical equipment and methods, microbial measurement/testing, and resistance to vector-borne diseases, etc., and can solve problems such as difficulties

Active Publication Date: 2020-09-04
ACADEMY OF MILITARY MEDICAL SCI
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The specific detection principle is: the two ends of the reporter RNA in the CRISPR reaction system are respectively modified with biotin and FAM. For positive samples, the double-labeled reporter RNA cut off by the Cas protein flows from the side of the sample pad to the binding pad due to capillary force. The FAM end of the reporter RNA will bind to colloidal gold particles, and the other end will be captured by streptavidin (C line) during chromatography, and the sheared reporter RNA-FAM-colloidal gold particle complex will bind to the T line The secondary antibody specifically binds to the T-line and C-line at the same time; however, in actual use, it is found that no matter the negative or positive sample, in the detection of LFCA test paper based on this detection principle, especially the sample concentration is low Although the color shades of the T line and C line in the negative and positive samples are different, bands will appear in both, which also brings certain difficulties to the interpretation of results that mainly rely on subjective naked eye observation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Line eliminating method immunochromatography test paper and application thereof in CRISPR nucleic acid test
  • Line eliminating method immunochromatography test paper and application thereof in CRISPR nucleic acid test
  • Line eliminating method immunochromatography test paper and application thereof in CRISPR nucleic acid test

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1. Nucleic acid detection kit based on CRISPR detection principle and "line elimination method" immunochromatography

[0054] 1. Preparation of nucleic acid detection kit based on CRISPR detection principle and "line elimination method" immunochromatography

[0055] 1. Preparation of "line elimination method" immunochromatographic test paper

[0056] Lateral flow test strips based on the disappearing line method (such as figure 1 Shown in A) Arranged according to the flow direction, it includes the sample pad containing colloidal gold-labeled rabbit-derived anti-FITC antibody, the NC membrane containing T-line and C-line, and the absorbent filter paper.

[0057] 1), sample pad containing colloidal gold-labeled rabbit-derived anti-FITC antibody

[0058] Rabbit-derived FITC antibody was purchased from Shanghai Sangong, article number: D110003

[0059] Colloidal gold solution: add 0.4mL 10% (mass volume ratio g:mL) of chloroauric acid and 0.4mL 10% (mass volume ...

Embodiment 2

[0095] Example 2. Comparison of the nucleic acid detection kit based on CRISPR detection principle and "line elimination method" immunochromatography with the existing CRISPR lateral flow chromatography test paper in the detection of new coronavirus nucleic acid

[0096] 1. Preparation of nucleic acid detection kit based on CRISPR detection principle and "line elimination method" immunochromatography

[0097] 1. Preparation of "line elimination method" immunochromatographic test paper

[0098] Same as 1 of embodiment 1;

[0099] 2. CRISPR reaction system

[0100] 1) Obtaining reporter RNA

[0101] Same as 2 of embodiment 1;

[0102] 2) Preparation of crRNA

[0103] The crRNA consists of the LwCas13a protein binding region and the target nucleic acid target sequence binding region.

[0104] The nucleotide sequence of the crRNA is sequence 2, wherein, the 1-38th in the sequence 2 is the region bound by the LwCas13a protein, and the 39-66th is the region bound by the target nu...

Embodiment 3

[0132] Example 3. The critical concentration repeatability of the nucleic acid detection kit based on the CRISPR detection principle and the "line elimination method" immunochromatography in the detection of novel coronavirus nucleic acids

[0133] 1. Preparation of nucleic acid detection kit based on CRISPR detection principle and "line elimination method" immunochromatography

[0134] Same as the one of embodiment 2;

[0135] 2. Detection of nucleic acid detection kit based on CRISPR detection principle and "line elimination method" immunochromatography

[0136] 1), Amplification of target nucleic acid

[0137] Obtained by embodiment 2, the sensitivity of the line disappearing test paper to novel coronavirus is 10 0 copies / μL, using 10 0 The standardized novel coronavirus nucleic acid of copies / μL is used as the target nucleic acid, and a negative control group (H 2 O).

[0138] Method is the same as the second of embodiment 2.

[0139] 2) CRISPR reaction

[0140] Met...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses line eliminating method immunochromatography test paper and application thereof in a CRISPR nucleic acid test. A kit provided by the invention comprises: 1) immunochromatography test paper; and 2) a CRISPR reaction system, wherein in a sample flow direction of the immunochromatography test paper sequentially comprises a sample pad containing a colloidal gold labelled antibody, an NC membrane contain a T line and a C line and water-absorbent filter paper; the T line is formed by streptavidin; the C line is formed by a secondary antibody of the colloidal gold labelled antibody; the CRISPR reaction system comprises report RNA, crRNA and Cas protein; and the Cas protein is in a second-class type V or type VI CRISPR system. Experiments of the invention prove that the test paper in the kit can realize high-sensitivity, high-specificity and convenient detection of multiple specific nucleic acids (pathogens, gene mutation and drug-resistant mutation) by binding a CRISPRnucleic acid detection system.

Description

technical field [0001] The invention relates to a "line elimination method" immunochromatographic test paper and its application in CRISPR nucleic acid detection, belonging to the technical field of molecular diagnosis. Background technique [0002] In recent years, CRISPR genome editing technology has triggered tremendous changes in the biological world. In 2017, researchers discovered the Leptotrichia wadei Cas13a protein (LwCas13a) that can be used for nucleic acid detection. By combining it with recombinant polymerase isothermal amplification technology (Reconbinase polymerase amplification, RPA), the system sensitivity was increased by 1 million times, and A highly sensitive and specific nucleic acid detection method SHERLOCK (Specific High Sensitivity Enzymatic Reporter UnLOCKing) with a sensitivity of single copy and a specificity of single base was established. The system has been used for the detection of Zika and dengue virus in biological samples (blood or urine)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/70C12Q1/6804C12N15/113C12N9/22
CPCC12Q1/701C12Q1/6804C12N15/113C12N9/22C12N2310/20C12Q2521/327C12Q2525/307C12Q2531/119C12Q2565/625Y02A50/30C12Q2563/131C12Q2565/137
Inventor 李浩孙岩松王彦贺董雪何雷
Owner ACADEMY OF MILITARY MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products